Board members
Ebba Åsly Fåhraeus (b 1963)
Chairman of the board - MBA
Ordinary boardmember since 2009. Has many years of experience in marketing and sales. Chief Communication Officer & Business Development Director Qeep Group AB. Previous VP Sales & Marketing Anoto AB, Strategic Business Development Manager with Raufoss United Group (Norway), international Product Manager with Johnson & Johnson and Sales and Marketing Manager with Cederroth and Mölnlycke.
Jacob Engellau (b 1963)
MD
Ordinary board member since 2011. Jacob Engellau is an associate professor at Lund University, where he in his roll as the head of radiation therapy has been initiating the implementation of novel medical technology in healthcare. Jacob is currently a physician at the Department of Oncology,Skåne University and at the Department of Oncology, Finsen Center, Rigshospitalet, Copenhagen, Denmark.
Thomas Laurell (b 1961)
Masterter of Engineering, PhD in Engineering
Ordinary board member since 2008. Professor in Medical and Chemical Microsensors at Lund Institute of Technology. Thomas Laurell has more than 20 years of experience in research and development with focus on nanobiomedical and Lab-On-A-Chip technologies.
-
Current assigments include: Boardmember of AcouSort AB, Picology AB, ISET AB, ScandiCandy AB and Scandi Fastighet AB.
-
Kenth Petersson (b 1956)
BA
Ordinary board member since 2011. Kenth Petersson has previously worked as an analyst and has extensive experience in the biotechnology industry. He is currently working as a business angel and principal owner of a number of biotech companies.
- Current assigments include: Chairman of the Board in AlphaBeta AB, Biocrine AB, Spiber Technologies AB and Science Pacific AB. Member of the Board in Alligator Bioscience AB and BioInvent AB.
- Holdings: None
Peter Ragnarsson (b. 1963)
MSc in Business Administration and Economics
Ordinary board member of Genovis since 2012. Peter Ragnarsson is CEO of LMK Ventures AB. Ragnarsson was previously CEO of Axis AB, Bell Group Plc and AudioDev AB. In addition, he has also held various positions at Niscayah Group AB, Securitas AB, Arjo BV and SET Revisionsbyrå.
- Other directorships and positions of trust: Ragnarsson is a board member of LMK Ventures AB, Hotel Kungsträdgården AB, Generic Sweden AB, Nocroc Ventures AB, Gullberg & Jansson AB, Aqilles Invest AB and LMK Hotels & Real Estate AB.
- Previous engagements: Niscayah Group AB, OnTime Logistics A/S, Hövding
Sverige AB.
- Holdings in Genovis: None.
Carina Schmidt (b 1958)
Master of Engineering
Ordinary board member since 2008. CEO of Athera Biotechnologies a company within the Karolinska Development portfolio. She has experience from 25 years in industry, both as an employee and owner-manager mainly in business development, international marketing and product management within the Life Science area.
Erik Walldén (b. 1949)
Ordinary board member of Genovis since 2012. Erik Walldén is CEO of the Swedish company Gyros, which is active in miniaturization of laboratory processes for protein analysis. Walldén was previously CEO of Swedish biotech companies Affibody Holding, Biacore International and Pyrosequencing. Walldén participated in the establishment of and has been active at the following companies: PerSeptive Biosystems Inc., Pharmacia Biosensor and Pharmacia Biotech.
- Other directorships and positions of trust: Deputy Chairman of the board of directors for Exiqon A/S, chairman of SwedenBIO Business&Finance Work Group and member of the board of directors for Erik Walldén AB, AffibodyAB and Tecan Group Ltd. as well as member of the fund company HealthIest.
- Previous engagements: Deputy board member at Berg Fastighetsaktiebolag.
- Holdings in Genovis: None.
